Placing of new h shares under general mandate
Filed with HKEX · Stock code 2565 · · 12 pages · English
Summary by 6ix AI
The proceeds from this placing will be allocated primarily for research and development of new products, repayment of loans, and general corporate purposes. The company has entered into a Placing Agreement with a sole placing agent to facilitate this transaction, which is subject to certain conditions.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from PegBio
- Form of proxy for use at the 2026 first extraordinary general meeting to be held on Thursday, November 12, 2026
- Notice of the 2026 first extraordinary general meeting
- (1) Proposed removal of auditor (2) proposed appointment of auditor (3) proposed change in use of proceeds from the global offering and (4) notice of the 2026 first extraordinary general meeting
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- 2026 Interim Report
Later from PegBio
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
- Cancellation of extraordinary general meeting and cancellation of book closure period
Follow PegBio into a list and get an email when it puts out news.
Follow PegBio